Leaflet MANINIL 1.75mg tablets
Indicated for: type 2 diabetes mellitus
Route of administration: oral
Substance: glibenclamide (sulfonylurea antidiabetic)
ATC: A10BB01 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas)
This medicine may lower blood sugar.
Glibenclamide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.
It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glibenclamide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).
Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, weight gain, dizziness, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.
General data about MANINIL 1.75mg
- Substance: glibenclamide
- Date of latest medicines list: 01-08-2018
- Product code: W07202003
- Concentration: 1.75mg
- Pharmaceutical form: tablets
- Quantity: 120
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for glibenclamide
- 1.75mg
- 3.5mg
- 5mg